 |
Cells produced using the AastromReplicelle System and SC-I Therapy Kit |
|---|---|
| Trade Name | |
| Orphan Indication | For use in patients receiving high dose chemotherapy who are unable to generate an acceptable dose of peripheral blood stem cells and who have a sufficient bone marrow aspirate without morphological evidence of tumor |
| USA Market Approval | USA |
| USA Designation Date | 2002-07-10 00:00:00 |
| Sponsor | Aastrom Biosciences Incorporated;P.O. Box 376;Ann Arbor, Michigan, 48106 |
